chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The vaccine site did not have any issues for the first ~72 hours. The site then turned red and a soft lump appeared. Tenderness started and has remained. Over the course of the week following vaccination, the lump turned from soft to hard. There is occasional itchiness to the site, particularly upon waking.
Presented to the ER with altered mental status 36-hrs after vaccination and suffered a witnessed cardiopulmonary arrest requiring defibrillation
Pain from shoulder to forearm since injec yesterday. Pt eval this am, skin mildly elev at site - diameter of a lemon. No redness @ site (+) warm. Streaking red on shoulder and forearm, pt advised BENADRYL she is pregn.
because of covid pandemic didn´t received second dose. 1st dose on sept 2020; This case was reported by a consumer and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on September 2020).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The reporter stated that, 2nd dose was not received due to covid pandemic, which led to social problem. The patient did not remember if received 2nd dose of Shingrix. The reporter asked if get dose now even if it might be third.
Hives; Pain in the same arm of injection; Fatigue; Headache; Nausea; Aches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain in the same arm of injection), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea) and PAIN (Aches) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INJECTION SITE PAIN (Pain in the same arm of injection), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea) and PAIN (Aches). On 03-Feb-2021, the patient experienced URTICARIA (Hives). On 28-Jan-2021, INJECTION SITE PAIN (Pain in the same arm of injection), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea) and PAIN (Aches) had resolved. At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included none.   Reporter did not allow further contact
rash all over body & except face,sinus & h/a;MD gave Solumdol Im also cortisone tabs
I go to work but I can breathe.  I said to my manager I can't work. I need to come back home. I drove my car very difficult. After I come home, I can't breathe so my husband called 911. I was fainting.  I check everything. I have a problem, I can't breathe when I read or phone. Now I am better than old. I don't know what happened. I think it is the problem when I take the vaccine.
Information has been received from a registered nurse referring to unspecified numbers of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On an unknown date these patients were vaccinated with improperly stored LIQUID PEDVAXHIB (lot # K025005, expiration date: 21-JUL-2017 or lot # K025006, expiration date: 22-JUL-2017 or lot #K016964, expiration date: 16-JUL-2017 or lot #K002747, expiration date: 09-DEC-2016 or lot #K008680, expiration date: 11-MAR-2017; strength, dose and route unknown). There was no information about concomitant therapy. No adverse effects were reported. This is of several reports received from the same reporter. Additional information has been requested.
APPROXIMATELY 10 MINUTES AFTER RECEIVING THE MODERNA COVID-19 VACCINE PT COMPLAINED OF NAUSEA, BLURRED VISION, LIGHTHEADEDNESS. SYMPTOMS PERSISTED FOR 2 HOURS.
No adverse event. AFC home was told 18 yo and over are eligible for vaccine.  sent employee that was 2 weeks shy of 18th birthday.  pharmacist did not notice age not old enough and patient received shot without incident.  patient will be 18 by 2nd dose.
Hearing loss in left ear discovered approximately 4.5 hours after shot.  Hearing level at an estimate 20% of normal.  Next morning hearing just slightly improved at an estimated 40% of normal with intense ringing in left ear only.
Patient was given booster of Moderna 1 month too soon,patient did not have adverse reactions. patient is aware the booster was given 1 mo early.
Information has been received from a currently 90 year old male patient referring to himself. There was no medical history or drug reaction/allergies reported. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (1 shot, subcutaneous, dose and lot # were unknown). No concomitant therapy was reported. On an unknown date after administration, the patient developed rash. No treatment was given to  him. The patient sought unspecified medical attention on an unknown date. The outcome of the event was unknown. Additional information is not expected since the reporter refused to answer further questions and no contact information was provided.
Injection given on 12/13/13 - patient developed a approx dime size soft tissue density with discoloration and post inflammatory changes - non-tender - noted on exam 1-13-14 R/O sterile abscess. 2-18-14 - on exam noted dime size density - debrided and expressed large amount of drainage - purulent oral and topically antibiotics started - culture taken.
I felt a burning and heavy sensation in my chest (diaphragm ) and sick to my stomach feeling. I can actually smell the medication in my nostrils.  I did not eat anything  before I got my shot.
24 hours after my booster my throat was swollen shut; rapid heart rate; shortness of breath; broke out into hives; booster; This is a spontaneous report from a contactable Other healthcare professional (patient). A 27-year-old female patient received third dose of BNT162B2 on 05Nov2021 06:30 pm at single dose on left arm for COVID-19 Immunization. Known allergies: Amoxicillin. Medical history included Shrimp. Concomitant medications were none. No other vaccine in four weeks. No other medications in two weeks. The patient previously took Amoxicillin and Known allergies: Amoxicillin. Historical vaccine included BNT162B2 dose 1 on 02Feb2021 (at age of 27 years old, fever and body soreness) 10:00 am on arm left for COVID-19 Immunization and experienced fever and body soreness, dose 2 on 22Feb2021 (at age of 27 years old, fever and body soreness) 10:00 am on left arm for COVID-19 Immunization and experienced fever and body soreness. Facility type vaccine: Pharmacy or Drug store. After dose 1 and 2 she had a fever and body soreness. 24 hours after her booster (06Nov2021 6:30 pm) her throat was swollen shut, rapid heart rate, shortness of breath, and broke out into hives. AE resulted in: [Emergency room/department or urgent care]. The outcome of the events was recovering. AE treatment: Emergency care in hospital and medicine. No COVID prior vaccination. Covid test post vaccination: Covid test type post vaccination= Nasal Swab, Covid test name post vaccination= Rapid, Covid test date= 06Nov2021, Covid test result= Negative.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up .; Sender's Comments: Based on the information currently available,The casual association between the reported events and suspected vaccine BNT162B2 cannot be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
erythematous, pruritic area 6cm x 8cm w/sl indurated, hard center 2cm x 4cm devel 24hr p/vax lt upper arm;
This spontaneous report as received from a consumer refers to himself, a male patient of unknown age. The patient reported an unspecified adverse reaction on an unspecified date in DEC-2013 after receiving PNEUMOVAX 23 (start date not provided). The outcome of the unspecified adverse reaction is unknown. No further information was provided. Additional information has been requested.
Patient was given a diluted dose of Pfizer Covid vaccine.  Medical assistant confused gray top vaccine with purple top vaccine (as we had ordered purple top vaccine from Immunet, Department of Health).  She followed instructions for giving purple top and therefore diluted the vial with 1.8 ml diluent.  Patient received diluted dose for her booster.  No adverse effects suffered.  Please note that we ordered the purple top vaccine and we were given instructions on how to administer the purple top vaccine.  We were not informed of the substitution to gray cap and we were not given updated instructions.  Also, the vials came in a purple bag.      Should patient repeat dose?
About 1-2 minutes after immunizing, patient stated she was light headed. We stayed with the patient as she passed out in the chair. We supported the patient in the chair, checked for breathing (yes), and called for code white. We tapped patient on shoulder and called out her name repeatedly. She regain consciousness in about 5 minutes as management and EMS arrived. Patient was taken to local hospital for observation and we notified her family doctor. We have not heard back from family doctor as to her current health status.
All over pruritis L arm swelling. Treated w/50mg benadryl IM.
Reddened non-raised rash to upper arm where vaccine was administered. Some warmth. Soreness per patient.
2 and half inches and jabbed her, 2 to 3 inches away and just poked it into her arm and it hurt; injection hurt; shot jabbed her into her arm from 3 inches away; it hurt immediately and this thing was my arm hurt real bad;  it''s red and it''s warm; hurts me as soon as she gave it; still painful; I had just stay in bed for first two days because of the pain; it''s red all around and it''s swollen and it''s warm; she''s got a round circle around the injection site, 3 and 4 inches around; warm and it''s red; it was sored as soon as she administered the injection; she''s got a round circle around the injection site, 3 and 4 inches around; warm and it''s red; it was sored as soon as she administered the injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 26Oct2021 (Lot number: 30145BA) at the age of 64 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: she is suffering from asthma, moderate asthma with no general lungs. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number:01, My first and second one was done at another center and I felt muscle pain), for Covid-19 Immunization, reaction(s): "I felt muscle pain"; Bnt162b2 (Dose Number:02, My first and second one was done at another center and I felt muscle pain), for Covid-19 Immunization, reaction(s): "I felt muscle pain". The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset Oct2021, outcome "unknown" and all described as "she''s got a round circle around the injection site, 3 and 4 inches around; warm and it''s red; it was sored as soon as she administered the injection"; VACCINATION SITE PAIN (non-serious) with onset 26Oct2021, outcome "not recovered", described as "2 and half inches and jabbed her, 2 to 3 inches away and just poked it into her arm and it hurt; injection hurt; shot jabbed her into her arm from 3 inches away"; PAIN (non-serious) with onset 26Oct2021, outcome "not recovered", described as "it hurt immediately and this thing was my arm hurt real bad;  it''s red and it''s warm; hurts me as soon as she gave it; still painful; I had just stay in bed for first two days because of the pain"; PERIPHERAL SWELLING (non-serious) with onset Oct2021, outcome "unknown", described as "it''s red all around and it''s swollen and it''s warm". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pain, vaccination site warmth, pain, peripheral swelling.  Follow-Up (04Nov2021): Follow-up attempts are completed. No further information is expected.
received the vaccine in the right arm in which she experienced injection site soreness; pain in my hip joint; I am having pain there, from my hip down to my knees and this is on my right side; This is a spontaneous report from a contactable consumer via medical information team. This female consumer reported for herself.  A 70-year-old female patient BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EL3306), via unspecified route of administration, in right arm on unspecified date (at the age of 70- year-old) as a dose 2, single and received first dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL0140), via unspecified route of administration on 27Jan2021 in right arm as a dose 1, single for COVID-19 immunization. Patient medical history included blood pressure high and high cholesterol. The concomitant medication of patient was not reported. On unspecified date the patient reported a side effect after receiving both doses of the COVID vaccine. Patient stated that she received the vaccine in the right arm in which she experienced injection site soreness and patient was still experiencing pain in her hip joint, slightly down her right leg and thigh. Patient also reported that she was having pain there, from her hip down to her knees and this was on her right side. Patient stated that she was on hold for 4 hours and wanted to talk to somebody about the vaccine because she got the two doses of vaccination and was on hold from 3 O clock this afternoon. Patient also stated that she read paper and on the side effects, on her right side her hip and her knee it was like she was having pain there, from her hip down to her knees and this was on her right side the side she got the vaccination. The patient underwent lab tests and procedures for blood work, and she dont know it was last week or the week before. Patient received the treatment of baby aspirin (Lot number: 86395886) and stated it didn't even help. The outcome of the events was unknown.  No follow-up attempts are possible; No further information is expected.
Mother reports swollen, red, hot to touch upper arm; just below injection site. No fever, SOB or other respiratory reaction. Symptoms noticed later the evening 8/10/17.
Sore arm; Diarrhea; Headache; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 12:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, chronic obstructive pulmonary disease (COPD), osteoarthritis, allergy to penicillin and hymenopter venom and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included clopidogrel bisulfate (PLAVIX), escitalopram oxalate (LEXAPRO), hydrochlorothiazide (MANUFACTURER UNKNOWN) and bupropion hydrochloride (WELLBUTRIN); all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. On 12May2021 at 07:30, the patient experienced sore arm, diarrhea, headache and malaise. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm, diarrhea, headache and malaise were resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
She has a bump in her mouth; Dental work done gums are inflamed; This is a spontaneous report from a contactable consumer. This is a spontaneous report from a contactable consumer, the patient. This female patient of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown),  dose 1, single dose via an unspecified route of administration on 11Jan2021 for COVID-19 vaccination.  Medical history included dental work on an unknown date. Concomitant medications were not reported. In Jan2021, the patient had dental work done and gums are inflamed and has a bump in her mouth. The events were reported as non-serious. The clinical outcome of gums are inflamed and has a bump in her mouth was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
pt recvd vax 20OCT94 & exp painful inj;It was followed by 4-5 days during which every arthritic joint of the pt's body was extremely painful;it was diff for pt to cont working as a secretary;since those 4-5 days of pain-pt has no pain
This case was reported by a physician via other manufacturer and described the occurrence of therapy non-responder in a patient who received ENGERIX B. Previously administered products included ENGERIX B (in series in 2002). Concurrent medical conditions included hepatitis c. On an unknown date, the patient received ENGERIX B at an unknown dose. On an unknown date, an unknown time after receiving ENGERIX B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to ENGERIX B. Additional information received: Nurse reported that a patient received Hepatitis B vaccine in series in 2002 on unspecified dates and started that the patient was non responder. The nurse also reported that she was aware a lot (unspecified amount) of patients that were non responders to ENGERIX. No further information was provided.
Information was received from a lawyer regarding a case in litigation involving a female patient, age and medical history not provided. In 2011 the patient was inoculated with ZOSTAVAX vaccine for routine adult health maintenance and the prevention of shingles by a physician assistant. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 20-MAR-2012 the patient was treated at a health center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
inject site warm but not red on 10FEB; 11FEB pt whinning & irritable all day; slept well in evening; knot appeared @ site 10FEB;
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (Lot# and route not reported). On an unknown date the patient experienced skin rash. It was unspecified if the patient sought medical attention. The outcome of skin rash is unknown. Additional information is not expected.
Pain and stiffness on right side of neck, back of head as of Monday 11/9/2015 - pain and stiffness still there.
Rash on left arm (warm to touch, pink) on Wednesday.  Took benedryl.  Woke up Thursday to extreme headache, joint and muscle pain, extreme lethargy. Took ibuprofen, water.  Slept almost 18 hours.  Still feeling faint muscle/joint pain and headache on Friday.
Patient had never received flu shot before January 2013. After getting shot patient started experiencing hives. Patient tried ruling out food allergies. Patient believes is an allergy to Thimerosal.
NauseaVomiting chest tightness Narrative:  chest tightness and nausea after getting 2nd vaccine.
Information was received from a nurse concerning a female patient who received GARDASIL doses on 18-MAR-2012 and 02-FEB-2012. The patient had not yet received the third dose. No adverse effect was reported. No further information was available. Additional information has been requested.
No reported adverse reaction currently, discovered patient given adult dose of Hep A so received 1 ml and was due for 0.5 ml
First generalized tonic clonic seizure the morning of 10/13 while hiking; no prior h/o seizure. Febrile to ~102F on 10/9,  low grade elevated temperature ~100F overnight preceding seizure. Suspect multifactorial (on wellbutrin, so lower seizure threshold; may have had some ongoing post vaccine fever as I had an impressive immune response symptom wise that contributed, +/- mild dehydraton/physical exertion). Waiting on EEG. Wanted to report just in case, even though I recognize it may have been coincidental.
Extreme fatigue accompanied by chest heaviness, severe muscle aches/ weakness , frontal headache and low grade fever( 99.7)  I am normally very active with a BMI of 21.5. I spent the day in bed and at one point had to sit on the bathroom floor because I had a feeling of chest heaviness that felt as if I was going to stop breathing.  I am an RN and kept telling myself this is just  the vaccine side effects and did not want to embarrass myself by going to the ER. I think if I were a layperson I may have gone.
Inadvertently gave TD instead of TDAP to patient. She was 31 weeks pregnant, expected to deliver in August 2022. No adverse reactions at the time in clinic setting. Called patient 06/30/2022, No S/S of any reactions, patient stated "I feel fine"
Red hot lump x3 days then rash, itchy & achy & had Flu like symptoms. Resolved 1-28-2013.
Vaccine was administered high on the deltoid resulting in pain in left shoulder with decreased ROM that lasted for 2 weeks.
After first dose a week or two later notices a lump on the bottom of my right breast, the same side I received my shot, right arm. It has  since reduced in size but a mammogram in coming week will determine if the lump is completely gone,